Masitinib
Tocris Bioscience, part of Bio-Techne | Catalog # 7705
Potent colony-stimulating factor 1 receptor (CSF-1R) tyroine kinase inhibitor
Key Product Details
Description
Potent colony-stimulating factor 1 receptor (CSF-1R) tyroine kinase inhibitor
Product Description
Masitinib is a potent inhibitor of the tyrosine kinase receptor colony-stimulating factor 1R (CSF-1R) (IC50 = 90 nM). It is also an NLRP3 inflammasome activator. Masitinib additionally inhibits the proteolytic activity of SARS-CoV-2 main protease (Mpro) and blocks viral replication, as well as acting as a PDGFRα/β inhibitor. In vivo, Masitinib ameliorates cognitive impairment in transgenic mice model of Alzheimer's disease, and slows disease progression in a rat model of amyotrophic lateral sclerosis (ALS). Orally bioavailable.Product Specifications
Molecular Weight
498.64
Formula
C28H30N6OS
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]benzamide
CAS Number
790299-79-5
PubChem ID
10074640
InChI Key
WJEOLQLKVOPQFV-UHFFFAOYSA-N
SMILES
O=C(NC1=CC=C(C(=C1)NC2=NC(=CS2)C=3C=NC=CC3)C)C4=CC=C(C=C4)CN5CCN(C)CC5
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 49.86 | 100 | |
| Ethanol | 4.99 | 10 |
Preparing Stock Solutions
for Masitinib
The following data is based on the product molecular weight 498.64
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.01 mL | 10.03 mL | 20.05 mL |
| 5 mM | 0.40 mL | 2.01 mL | 4.01 mL |
| 10 mM | 0.20 mL | 1.00 mL | 2.01 mL |
| 50 mM | 0.04 mL | 0.20 mL | 0.40 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Drayman Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. Science 2021 PMID: 34285133
- Ettcheto Masitinib for the treatment of Alzheimer's disease. Neurodegener.Dis.Manag. 2021 PMID: 34412534
- Li Effects of chronic Masitinib treatment in APPswe/PSEN1dE9 transgenic mice modeling Alzheimer's disease. J.Alzheimers.Dis. 2020 PMID: 32623401
- Trias Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J.Neuroinflammation 2016 PMID: 27400786
- Martínez-Ortega In silico characterization of Masitinib interaction with SARS-CoV-2 main protease. ChemMedChem. 2021 PMID: 34142459
Product Specific Notices for Masitinib
For research use only
Loading...
Loading...